Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 6NIH 4OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

HIV Infections 1

Interventions

Specimen Handling 68Magnetic Resonance Spectroscopy 53Cyclophosphamide 45Vincristine 38Radiotherapy 31Radiation 31Cisplatin 31Carboplatin 30Dexamethasone 27Etoposide 26Biopsy 26Doxorubicin 25Prednisone 18daratumumab 17Radiotherapy, Intensity-Modulated 17durvalumab 16Platinum 16Paclitaxel 16Irinotecan 16Cytarabine 16Gemcitabine 151,2-diaminocyclohexaneplatinum II citrate 15Observation 14Methotrexate 14Leucovorin 14Docetaxel 14Lenalidomide 13X-Rays 12Watchful Waiting 12Rituximab 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Human Papillomavirus Recombinant Vaccine nonavalent × 1 year × Clear all
NCT03284866 2026-01-28

COVENANT

AIDS Malignancy Consortium

Phase 3 Completed
536 enrolled

HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡